Difference between revisions of "Sekulic A, et al. N. Engl. J. Med. (2012) cited as Ref 599 in DOI: 10.1038/s41392-020-0110-5 (Q9862)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Sekulic A, #quickstatements; #temporary_batch_1589996169159) |
(Created claim: Page(s) (P105): 2171-2179, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1056/NEJMoa1113713 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 22670903 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2012
| ||||||||||||||
| Property / Publication Date: 2012 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | N. Engl. J. Med. | ||||||||||||||
| Property / Published In Name String: N. Engl. J. Med. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 366 | ||||||||||||||
| Property / Volume: 366 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Efficacy and safety of vismodegib in advanced basal-cell carcinoma (English) | ||||||||||||||
| Property / title: Efficacy and safety of vismodegib in advanced basal-cell carcinoma (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 2171-2179 | ||||||||||||||
| Property / Page(s): 2171-2179 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:46, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Sekulic A, et al. N. Engl. J. Med. (2012) cited as Ref 599 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Sekulic A
0 references
2012
0 references
N. Engl. J. Med.
0 references
366
0 references
Efficacy and safety of vismodegib in advanced basal-cell carcinoma (English)
0 references
2171-2179
0 references
